drugset / Trial / NCT01904149

Oral Treatment for Gynaecological Post-operative Pain With Dexketoprofen Trometamol and Tramadol Hydrochloride

NCT01904149 ↗

Phase 3 Completed 606 enrolled Menarini Group
RandomizedParallel-groupTriple-blindTreatment

Summary

This study aims to evaluate the analgesic efficacy of single and repeated doses of fixed combination of dexketoprofen trometamol (DKP) and tramadol hydrochloride (TRAM) in comparison to the single agents (and placebo for the single dose phase only). Approximately 600 female patients presenting moderate to severe pain after a total/subtotal abdominal hysterectomy are eligible to be randomised provided that they experience moderate to severe pain on the day after surgery.

Timeline

Start
2013-05
Primary completion
2014-05
Completion
2014-05

Outcome

Met primary endpoint

paper The study results confirmed the superiority of the combination over the single agents in terms of the primary endpoint (p <0.001). PMID 26801905 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexketoprofen Small molecule 25 mg Oral
Subject Tramadol Other / unclassified 75 mg Oral
Subject Tramadol Other / unclassified 100 mg Oral

Indications

No indication recorded.